Complexities in Assessing Health Risks of Anabolic Steroid Abuse

Abstract

The misuse of anabolic androgenic steroids (AAS) has been linked to a broad spectrum of adverse effects, ranging from mild symptoms like acne and gynecomastia to severe health risks, including cardiovascular complications. However, establishing causality for these outcomes is hindered by significant methodological limitations in many studies, which often rely on case reports, uncontrolled cohorts, or retrospective analyses. Additionally, numerous confounding factors complicate the interpretation of results, such as the use of counterfeit or adulterated drugs, excessive dosing, prolonged use, polypharmacy, and the absence of medical oversight. This letter raises critical considerations for analyzing the health effects of AAS misuse, emphasizing the need to account for pre-existing health conditions, drug quality, dosing regimens, and concurrent substance use. Factors such as the duration of supraphysiological dosing, lifetime exposure, and whether users were monitored by healthcare professionals are crucial in evaluating risks. The chaotic and uncontrolled context of AAS abuse, often marked by high doses and the simultaneous use of legal and illegal substances, presents significant challenges to identifying specific causal relationships. While the dangers of prolonged, unsupervised AAS misuse are well-documented, attributing precise causality to AAS in adverse health events remains complex. This discussion underscores the importance of robust methodologies and critical evaluation in future research to better understand the health risks associated with AAS and to mitigate potential harm.